Hormone Refractory Prostate Cancer

specific

Prostate carcinoma that is resistant to treatment.

37

Centers

4

Active Trials

$1M

Cancer Funding

Top Centers for Hormone Refractory Prostate Cancer(37)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
70.9
2
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
High-Volume Research Center
70.9
3
NCI Comprehensive
High-Volume Research Center
70.9
4
High-Volume Research Center
70.9
5
NCI Comprehensive
Active Research Program
65.9
648.4
7
NCI Comprehensive
48.4
848.4
9
NCI Comprehensive
48.4
10
NCI Comprehensive
48.4
11
NCI Comprehensive
48.4
1248.4
1348.4
14
NCI Comprehensive
48.4
15
NCI Comprehensive
48.4
16
NCI Comprehensive
48.4
17
NCI Comprehensive
48.4
1848.4
19
NCI Clinical
48.4
20
NCI Comprehensive
48.4
2148.4
22
NCI Comprehensive
48.4
2348.4
2448.4
25
NCI Comprehensive
48.4
2648.4
27
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
48.4
2848.4
29
NCI Comprehensive
48.4
3048.4
3148.4
3248.4
3348.4
3448.4
3548.4
3648.4
37
BC CancerVancouver, BC
48.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →